Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain

Journal of Biological Chemistry

Volumn 292, Issue 22, 2017, Pages 9345-9357

  Kovachev, Petar Stefanov ^a   Banerjee, Debapriya ^a   Rangel, Luciana Pereira ^b   Eriksson, Jonny ^c   Pedrote, Murilo M ^b   Martins Dinis, Mafalda Maria D C ^b   Edwards, Katarina ^c   Cordeiro, Yraima ^b   Silva, Jerson L ^b   Sanyal, Suparna ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL MODIFICATION; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIGHT SCATTERING; NUCLEIC ACIDS; PROTEINS; RNA; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

AMORPHOUS AGGREGATION; BIMODAL BEHAVIOR; HUMAN CANCER; INTRINSIC FLUORESCENCE; PROTEIN-PROTEIN INTERACTIONS; SURFACE INTERACTIONS; THIOFLAVIN T; TUMOR SUPPRESSOR PROTEINS;

AGGLOMERATION;

OLIGOMER; PROTEIN P53; RNA; PROTEIN AGGREGATE; TP53 PROTEIN, HUMAN;

ARTICLE; BACILLUS SUBTILIS; BIOACCUMULATION; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN RNA BINDING; RNA SEQUENCE; CHEMISTRY; GENETICS; HUMAN; METABOLISM;

HUMANS; PROTEIN AGGREGATES; PROTEIN DOMAINS; RNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85020253860     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.762096     Document Type: Article

References (71)

1. Vousden, K. H., and Lane, D. P. (2007) P53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283
2. Prives, C., and Hall, P. (1999) The p53 pathway. J. Pathol. 187, 112-126
3. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
4. Muller, P. A., and Vousden, K. H. (2013) p53 mutations in cancer. Nat. Cell Biol. 15, 2-8
5. Ishimaru, D., Andrade, L. R., Teixeira, L. S., Quesado, P. A., Maiolino, L. M., Lopez, P. M., Cordeiro, Y., Costa, L. T., Heckl, W. M., Weissmüller, G., Foguel, D., and Silva, J. L. (2003) Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry 42, 9022-9027
6. Joerger, A. C., and Fersht, A. R. (2008) Structural biology of the tumor suppressor p53. Annu. Rev. Biochem. 77, 557-582
7. Khoury, M. P., and Bourdon, J.-C. (2011) p53 Isoforms: an intracellular microprocessor? Genes Cancer 2, 453-465
8. Moore, H. C., Jordan, L. B., Bray, S. E., Baker, L., Quinlan, P. R., Purdie, C. A., Thompson, A. M., Bourdon, J.-C., and Fuller-Pace, F. V. (2010) The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53 and is inversely associated with Δ133p53 expression in breast cancer. Oncogene 29, 6475-6484
9. Gong, L., and Chen, J. (2016) Δ113p53/Δ133p53 converts P53 from a repressor to a promoter of DNA double-stand break repair. Mol. Cell Oncol. 3, e1033587
10. Davidson, W. R., Kari, C., Ren, Q., Daroczi, B., Dicker, A. P., and Rodeck, U. (2010) Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos. BMC Dev. Biol. 10, 102
11. Olivares-Illana, V., and Fåhraeus, R. (2010) p53 isoforms gain functions. Oncogene 29, 5113-5119
12. Giaccia, A. J., and Kastan, M. B. (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983
13. Vousden, K. H., and Vande Woude, G. F. (2000) The ins and outs of p53. Nat. Cell Biol. 2, E178-E180
14. Lane, D. P. (1992) p53, guardian of the genome. Nature 358, 15-16
15. Bell, S., Klein, C., Müller, L., Hansen, S., and Buchner, J. (2002) p53 contains large unstructured regions in its native state. J. Mol. Biol. 322, 917-927
16. Friedler, A., Veprintsev, D. B., Hansson, L. O., and Fersht, A. R. (2003) Kinetic instability of p53 core domain mutants: implications for rescue by small molecules. J. Biol. Chem. 278, 24108-24112
17. Butler, J. S., and Loh, S. N. (2003) Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain. Biochemistry 42, 2396-2403
18. Ishimaru, D., Maia, L. F., Maiolino, L. M., Quesado, P. A., Lopez, P. C., Almeida, F. C., Valente, A. P., and Silva, J. L. (2003) Conversion of wildtype p53 core domain into a conformation that mimics a hot-spot mutant. J. Mol. Biol. 333, 443-451
19. Rangel, L. P., Costa, D. C., Vieira, T. C., and Silva, J. L. (2014) The aggregation of mutant p53 produces prion-like properties in cancer. Prion 8, 75-84
20. Ano Bom, A. P., Rangel, L. P., Costa, D. C., de Oliveira, G. A., Sanches, D., Braga, C. A., Gava, L. M., Ramos, C. H., Cepeda, A. O., Stumbo, A. C., De Moura Gallo, C. V., Cordeiro, Y., and Silva, J. L. (2012) Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. J. Biol. Chem. 287, 28152-28162
21. Forget, K. J., Tremblay, G., and Roucou, X. (2013) p53 Aggregates penetrate cells and induce the co-aggregation of intracellular p53. PLoS ONE 8, e69242
22. Silva, J. L., De Moura Gallo, C. V., Costa, D. C., and Rangel, L. P. (2014) Prion-like aggregation of mutant p53 in cancer. Trends Biochem. Sci. 39, 260-267
23. Macedo, B., Millen, T. A., Braga, C. A., Gomes, M. P., Ferreira, P. S., Kraineva, J., Winter, R., Silva, J. L., and Cordeiro, Y. (2012) Nonspecific prion protein-nucleic acid interactions lead to different aggregates and cytotoxic species. Biochemistry 51, 5402-5413
24. Silva, J. L., and Cordeiro, Y. (2016) The "Jekyll and Hyde" actions of nucleic acids on the prion-like aggregation of proteins. J. Biol. Chem. 291, 15482-15490
25. Fontoura, B. M., Atienza, C. A., Sorokina, E. A., Morimoto, T., and Carroll, R. B. (1997) Cytoplasmic p53 polypeptide is associated with ribosomes. Mol. Cell Biol. 17, 3146-3154
26. Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., and Deppert, W. (1995) Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14, 4442-4449
27. Yoshida, Y., Izumi, H., Torigoe, T., Ishiguchi, H., Yoshida, T., Itoh, H., and Kohno, K. (2004) Binding of RNA to p53 regulates its oligomerization and DNA-binding activity. Oncogene 23, 4371-4379
28. Riley, K. J., and Maher, L. J., 3rd (2007) p53 RNA interactions: new clues in an old mystery. RNA 13, 1825-1833
29. Riley, K. J., Ramirez-Alvarado, M., and Maher, L. J., 3rd (2007) RNA-p53 interactions in vitro. Biochemistry 46, 2480-2487
30. Levy, C. B., Stumbo, A. C., Ano Bom, A. P., Portari, E. A., Cordeiro, Y., Carneiro, Y., Silva, J. L., and De Moura-Gallo, C. V. (2011) Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors. Int. J. Biochem. Cell Biol. 43, 60-64
31. Pennisi, E. (1996) Filling in the blanks in the p53 protein structure. Science 274, 921-922
32. Ishimaru, D., Ano Bom, A. P., Lima, L. M., Quesado, P. A., Oyama, M. F., de Moura Gallo, C. V., Cordeiro, Y., and Silva, J. L. (2009) Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation. Biochemistry 48, 6126-6135
33. Wang, G., and Fersht, A. R. (2015) Mechanism of initiation of aggregation of p53 revealed by φ-value analysis. Proc. Natl. Acad. Sci. U.S.A. 112, 2437-2442
34. Ishimaru, D., Lima, L. M., Maia, L. F., Lopez, P. M., Ano Bom, A. P., Valente, A. P., and Silva, J. L. (2004) Reversible aggregation plays a crucial role on the folding landscape of p53 core domain. Biophys. J. 87, 2691-2700
35. Lakowicz, J. R. (2006) Principles of Fluorescence Spectroscopy (Lakowicz, J. R., ed), Springer US, Boston, MA 10.1007/978-0-387-46312-4
36. Bullock, A. N., Henckel, J., DeDecker, B. S., Johnson, C. M., Nikolova, P. V., Proctor, M. R., Lane, D. P., and Fersht, A. R. (1997) Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl. Acad. Sci. U.S.A. 94, 14338-14342
37. Munishkina, L. A., and Fink, A. L. (2007) Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins. Biochim. Biophys. Acta 1768, 1862-1885
38. Bruggink, K. A., Müller, M., Kuiperij, H. B., and Verbeek, M. M. (2012) Methods for analysis of amyloid-β aggregates. J. Alzheimers Dis. 28, 735-758
39. Biancalana, M., and Koide, S. (2010) Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 1804, 1405-1412
40. Sugimoto, S., Arita-Morioka, K.-I., Mizunoe, Y., Yamanaka, K., and Ogura, T. (2015) Thioflavin T as a fluorescence probe for monitoring RNA metabolism at molecular and cellular levels. Nucleic Acids Res. 43, e92
41. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489
42. Glabe, C. G. (2004) Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem. Sci. 29, 542-547
43. Silva, J. L., Lima, L. M., Foguel, D., and Cordeiro, Y. (2008) Intriguing nucleic-acid-binding features of mammalian prion protein. Trends Biochem. Sci. 33, 132-140
44. Silva, J. L., Gomes, M. P., Vieira, T. C., and Cordeiro, Y. (2010) PrP interactions with nucleic acids and glycosaminoglycans in function and disease. Front. Biosci. (Landmark Ed) 15, 132-150
45. Lima, L. M., Cordeiro, Y., Tinoco, L. W., Marques, A. F., Oliveira, C. L., Sampath, S., Kodali, R., Choi, G., Foguel, D., Torriani, I., Caughey, B., and Silva, J. L. (2006) Structural insights into the interaction between prion protein and nucleic acid. Biochemistry 45, 9180-9187
46. Liu, C., and Zhang, Y. (2011) Nucleic acid-mediated protein aggregation and assembly. Adv. Protein Chem. Struct. Biol. 84, 1-40
47. Cordeiro, Y., Macedo, B., Silva, J. L., and Gomes, M. P. B. (2014) Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases. Biophys. Rev. 6, 97-110 10.1007/s12551-013-0132-0
48. Sanyal, S. C., Pal, S., Chowdhury, S., and DasGupta, C., and Chaudhuri, S. (2002) 23S rRNA assisted folding of cytoplasmic malate dehydrogenase is distinctly different from its self-folding. Nucleic Acids Res. 30, 2390-2397
49. Chattopadhyay, S., Das, B., Bera, A. K., Dasgupta, D., and Dasgupta, C. (1994) Refolding of denatured lactate dehydrogenase by Escherichia coli ribosomes. Biochem. J. 300, 717-721
50. Pang, Y., Kurella, S., Voisset, C., Samanta, D., Banerjee, D., Schabe, A., Das Gupta, C., Galons, H., Blondel, M., and Sanyal, S. (2013) The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition. J. Biol. Chem. 288, 19081-19089
51. Reis, S. D., Pang, Y., Vishnu, N., Voisset, C., Galons, H., Blondel, M., and Sanyal, S. (2011) Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding. Biochimie 93, 1047-1054
52. Tribouillard-Tanvier, D., Dos Reis, S., Gug, F., Voisset, C., Béringue, V., Sabate, R., Kikovska, E., Talarek, N., Bach, S., Huang, C., Desban, N., Saupe, S. J., Supattapone, S., Thuret, J.-Y., Chédin, S., et al. (2008) Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs. PLoS ONE 3, e2174
53. Banerjee, D., and Sanyal, S. (2014) Protein folding activity of the ribosome (PFAR): a target for antiprion compounds. Viruses 6, 3907-3924
54. Kocisko, D. A., Vaillant, A., Lee, K. S., Arnold, K. M., Bertholet, N., Race, R. E., Olsen, E. A., Juteau, J. M., and Caughey, B. (2006) Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob. Agents Chemother. 50, 1034-1044
55. Cordeiro, Y., and Silva, J. L. (2005) The hypothesis of the catalytic action of nucleic acid on the conversion of prion protein. Protein Pept. Lett. 12, 251-255
56. Colvin, V. L., and Kulinowski, K. M. (2007) Nanoparticles as catalysts for protein fibrillation. Proc. Natl. Acad. Sci. U.S.A. 104, 8679-8680
57. Brambilla, D., Le Droumaguet, B., Nicolas, J., Hashemi, S. H., Wu, L. P., Moghimi, S. M., Couvreur, P., and Andrieux, K. (2011) Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues. Nanomedicine 7, 521-540
58. Gray, M. J., Wholey, W. Y., Wagner, N. O., Cremers, C. M., Mueller-Schickert, A., Hock, N. T., Krieger, A. G., Smith, E. M., Bender, R. A., Bardwell, J. C., Jakob, U. (2014) Polyphosphate is a primordial chaperone. Mol. Cell 53, 689-699
59. Pal, S., Chandra, S., Chowdhury, S., Sarkar, D., Ghosh, A. N., and Gupta, C. D. (1999) Complementary role of two fragments of domain V of 23 S ribosomal RNA in protein folding. J. Biol. Chem. 274, 32771-32777
60. Samanta, D., Mukhopadhyay, D., Chowdhury, S., Ghosh, J., Pal, S., Basu, A., Bhattacharya, A., Das, A., Das, D., and DasGupta, C. (2008) Protein folding by domain V of Escherichia coli 23S rRNA: specificity of RNAprotein interactions. J. Bacteriol. 190, 3344-3352
61. Pathak, B. K., Mondal, S., Ghosh, A. N., and Barat, C. (2014) The ribosome can prevent aggregation of partially folded protein intermediates: studies using the Escherichia coli ribosome. PLoS ONE 9, e96425
62. Das, D., Das, A., Samanta, D., Ghosh, J., Dasgupta, S., Bhattacharya, A., Basu, A., Sanyal, S., and Das Gupta, C. (2008) Role of the ribosome in protein folding. Biotechnol. J. 3, 999-1009
63. Costa, D. C., de Oliveira, G. A., Cino, E. A., Soares, I. N., Rangel, L. P., and Silva, J. L. (2016) Aggregation and prion-like properties of misfolded tumor suppressors: is cancer a prion disease? Cold Spring Harb. Perspect. Biol. 8, a023614
64. Kim, S., and An, S. S. (2016) Role of p53 isoforms and aggregations in cancer. Medicine 95, e3993
65. Avery-Kiejda, K. A., Morten, B., Wong-Brown, M. W., Mathe, A., and Scott, R. J. (2014) The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome. Carcinogenesis 35, 586-596
66. Takahashi, R., Giannini, C., Sarkaria, J. N., Schroeder, M., Rogers, J., Mastroeni, D., and Scrable, H. (2013) p53 isoform profiling in glioblastoma and injured brain. Oncogene 32, 3165-3174
67. Banerjee, D., Vovusha, H., Pang, Y., Oumata, N., Sanyal, B., and Sanyal, S. (2014) Spectroscopic and DFT studies on 6-Aminophenanthridine and its derivatives provide insights in their activity towards ribosomal RNA. Biochimie 97, 194-199
68. Holm, M., Borg, A., Ehrenberg, M., and Sanyal, S. (2016) Molecular mechanism of viomycin inhibition of peptide elongation in bacteria. Proc. Natl. Acad. Sci. U.S.A. 113, 978-983
69. Almgren, M., Edwards, K., and Karlsson, G. (2000) Cryo transmission electron microscopy of liposomes and related structures. Colloids and Surfaces 174, 3-21
70. Petrov, A. S., Bernier, C. R., Gulen, B., Waterbury, C. C., Hershkovits, E., Hsiao, C., Harvey, S. C., Hud, N. V., Fox, G. E., Wartell, R. M., and Williams, L. D. (2014) Secondary structures of rRNAs from all three domains of life. PLoS ONE 9, e88222
71. Gruber, A. R., Lorenz, R., Bernhart, S. H., Neuböck, R., and Hofacker, I. L. (2008) The Vienna RNA websuite. Nucleic Acids Res. 36, W70-W74